Aquestive Therapeutics (AQST) Total Debt (2016 - 2026)
Aquestive Therapeutics (AQST) total debt from Dec 31, 2016 to Mar 31, 2026. The current Aquestive Therapeutics (AQST) total debt is $175M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
Aquestive Therapeutics (AQST) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +11.06% |
| 3 Years TTM | +2.22% |
| 5 Years TTM | +12.12% |
| All Time TTM | +32.37% |
Annual Total Debt change of Aquestive Therapeutics (AQST)
| Year | Total Debt | Change |
|---|---|---|
| 2025 | $194M | +20.12% |
| 2024 | $162M | -1.42% |
| 2023 | $164M | -6.67% |
| 2022 | $176M | +21.85% |
| 2021 | $144M | +29.40% |
| 2020 | $111M | +31.65% |
| 2019 | $85M | +10.20% |
| 2018 | $77M | +10.29% |
| 2017 | $70M | N/A |
| 2016 | $0 | N/A |
Comparison Aquestive Therapeutics (AQST) total debt with competitors
Aquestive Therapeutics (AQST) total debt is $175.18M.